LRMR as of Nov 1 · 07:08 ET

LRMRNasdaqPharmaceutical Preparations

Larimar Therapeutics, Inc. · Brief

Next report

3 days

Nov 4 · before openest.Q3 FY26

Earnings

Expected move

Inputs

±37.0%implied · straddle

1.563.38

spot 2.47exp Nov 20ATM strike 2.5ATM straddle 1.08IV 229%

Oct 30 close

Expected move

Inputs

Implied vs realized

8 reportsHistory

0 of 8≥ implied

avg implied: ±35.8%
avg realized: ±8.2%

Mar 24 '25±40.5%▼−10.24%×0.25

Apr 30 '25±18.7%▲+10.88%×0.58

Aug 14 '25±37.1%▲+14.52%×0.39

Nov 5 '25±35.9%▼−15.26%×0.42

Jan 12 '26±99.8%▲+2.46%×0.02

Q1 FY26±14.0%▲+3.95%×0.28

May 14 '26±21.5%▼−5.12%×0.24

Q2 FY26±18.6%▲+3.27%×0.18

quarterimplied−100%0+100%realized×

Q2 FY26±18.6%▲+3.27%×0.18

May '26±21.5%▼−5.12%×0.24

Q1 FY26±14.0%▲+3.95%×0.28

Jan '26±99.8%▲+2.46%×0.02

Nov '25±35.9%▼−15.26%×0.42

Aug '25±37.1%▲+14.52%×0.39

2 older reports

Apr '25±18.7%▲+10.88%×0.58

Mar '25±40.5%▼−10.24%×0.25

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 4 report · est.

Bull2 of 4

3tracked funds holding the companyN-PORT · Aug 31 '26

163managers reporting positions in the latest quarterly filings13F · Jun 30 '26

Bear2 of 3

8 of 8recent moves that landed below options implied rangesEarnings history

15managers holding the majority of reported value13F · Jun 30 '26

AI captions · Oct 26 '26once per report · top 2 per case

Linked exposure

LRMR report session

No linked exposure.

Latest changes

30 daysAll changes

Oct 21impliedImplied move: ±37.9% into Nov 4 earnings (Oct 21 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.